Prokidney Corp.

Prokidney Corp.

World Rank (Aug-2026)
13118
Market Cap (Aug-2026)
0.402 Billion USD
Market Cap (Mar-08-2026)
0.692 Billion USD
World Rank (Jan-05-2024)
6,039
Market Cap (Jan-05-2024)
1.812 Billion USD
World Rank (Jul-30-2023)
4,581
Market Cap (Jul-30-2023)
2.807 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PROK
Employee Count
77
Employee Count as of Date
As on 2021
Headquarters City/State
North Carolina
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1 Million USD
Annual Operating Income in USD
-165 Million USD
Annual Net Income in USD
-69 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
336 Million USD
Total Liabilities in USD
35 Million USD
Total Equity in USD
-1,011 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Biotechnology
Healthcare
Health Care Diagnostics
Healthcare Service
Company Website
PROKIDNEY CORP.
Company Profile

ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease using a patient’s own cells.

The headquarters is in USA.

IPO Year
2021
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share